These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30202231)

  • 1. Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells.
    Nassir AM; Shahzad N; Ibrahim IAA; Ahmad I; Md S; Ain MR
    Saudi Pharm J; 2018 Sep; 26(6):876-885. PubMed ID: 30202231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of apoptotic effects of mPEG-b-PLGA coated iron oxide nanoparticles as a eupatorin carrier on DU-145 and LNCaP human prostate cancer cell lines.
    Tousi MS; Sepehri H; Khoee S; Farimani MM; Delphi L; Mansourizadeh F
    J Pharm Anal; 2021 Feb; 11(1):108-121. PubMed ID: 33717617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate Nanoparticles Containing Curcumin and Resveratrol: Preparation, Characterization, and In Vitro Evaluation Against DU145 Prostate Cancer Cell Line.
    Saralkar P; Dash AK
    AAPS PharmSciTech; 2017 Oct; 18(7):2814-2823. PubMed ID: 28397161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
    Hsieh TC; Wu JM
    Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
    Ray S; Ghosh Ray S; Mandal S
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy.
    Wan S; Zhang L; Quan Y; Wei K
    R Soc Open Sci; 2018 Nov; 5(11):181457. PubMed ID: 30564426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells.
    Gryparis EC; Hatziapostolou M; Papadimitriou E; Avgoustakis K
    Eur J Pharm Biopharm; 2007 Aug; 67(1):1-8. PubMed ID: 17303395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Resveratrol Tetramer r-Viniferin Induces a Cell Cycle Arrest Followed by Apoptosis in the Prostate Cancer Cell Line LNCaP.
    Empl MT; Albers M; Wang S; Steinberg P
    Phytother Res; 2015 Oct; 29(10):1640-5. PubMed ID: 26331691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
    Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
    Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and in vitro antitumor activity of polymeric nanoparticles loaded with Uncaria tomentosa extract.
    Ribeiro AF; Santos JF; Mattos RR; Barros EGO; Nasciutti LE; Cabral LM; Sousa VP
    An Acad Bras Cienc; 2020; 92(1):e20190336. PubMed ID: 32321026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
    Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
    Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles.
    Gumireddy A; Christman R; Kumari D; Tiwari A; North EJ; Chauhan H
    AAPS PharmSciTech; 2019 Mar; 20(4):145. PubMed ID: 30887133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
    Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line.
    Tabatabaei Mirakabad FS; Akbarzadeh A; Milani M; Zarghami N; Taheri-Anganeh M; Zeighamian V; Badrzadeh F; Rahmati-Yamchi M
    Artif Cells Nanomed Biotechnol; 2016; 44(1):423-30. PubMed ID: 25229832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells.
    Richa S; Dey P; Park C; Yang J; Son JY; Park JH; Lee SH; Ahn MY; Kim IS; Moon HR; Kim HS
    Biomol Ther (Seoul); 2020 Mar; 28(2):184-194. PubMed ID: 31476841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
    Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
    Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization and cytotoxic evaluation of bovine serum albumin nanoparticles encapsulating 5-methylmellein: A secondary metabolite isolated from Xylaria psidii.
    Arora D; Kumar A; Gupta P; Chashoo G; Jaglan S
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5126-5130. PubMed ID: 29100800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-modified PLGA nanoparticle delivery of triplex forming oligonucleotide for targeted prostate cancer therapy.
    Jiao J; Zou Q; Zou MH; Guo RM; Zhu S; Zhang Y
    Neoplasma; 2016; 63(4):569-75. PubMed ID: 27268920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo.
    Lu L; Li K; Mao YH; Qu H; Yao B; Zhong WW; Ma B; Wang ZY
    Int J Oncol; 2017 Oct; 51(4):1089-1103. PubMed ID: 28849003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.